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Abstract
Introduction: Mycobacterium avium complex (MAC) lung disease presenting as a solitary pulmonary nodule
(MAC-SPN) is often asymptomatic, is more common in middle to old age, and mimics lung cancer or tuberculoma.
We report herein a case of MAC-SPN in an immunocompetent young adult patient, presenting with persistent
chest pain and a subacutely progressive nodule with high intense 18F-fluorodeoxyglucose uptake. Histological
examination of resected specimens revealed pleurisy, which is a rare finding of MAC-SPN.
Case presentation: A 36-year-old Japanese male presented with chest pain and a subacutely progressive pulmonary
nodule. Positron emission tomography-computed tomography showed high intense 18F-fluorodeoxyglucose uptake in
the nodule. Owing to his continuous chest pain and subacutely progressive nodules, wedge resection was performed
using video-assisted thoracoscopic surgery. Histological examination revealed an epithelioid granuloma and pleurisy,
and the lung tissue culture was positive for mycobacteria identified as M. avium.
Conclusion: This is the first report of MAC-SPN occurring with persistent chest pain, suggesting that MAC should be
considered in the differential diagnosis of a solitary pulmonary nodule, even for patients who experience persistent
chest pain. As in the present case, surgical resection with video-assisted thoracoscopic surgery is a reasonable
approach to the diagnosis and treatment of MAC-SPN with possible malignancy, especially as MAC
can be diagnosed using resected lung tissue culture with histological confirmation.
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Introduction
Mycobacterium avium complex (MAC) lung disease com-
monly presents as upper lobe fibrocavitary or nodular
bronchiectatic forms of pulmonary disease and occasion-
ally presents as a solitary pulmonary nodule (MAC-SPN)
[1]. MAC-SPN is often asymptomatic, is more common in
middle to old age, and mimics lung cancer or tuberculoma
[2–4]. We report a case of MAC-SPN in an immunocom-
petent young adult patient, presenting with persistent
chest pain and a subacutely progressive nodule with high
intense 18F-fluorodeoxyglucose (FDG) uptake. Histological
examination of resected specimens revealed pleurisy,
which is a rare finding of MAC-SPN.
Case presentation
A 36-year-old Japanese male was referred to our hospital
because of persistent chest pain and a subacutely pro-
gressive pulmonary nodule. Four weeks prior to his
referral to our hospital, he began to experience chest
pain that increased in severity on inspiration. He visited a
private hospital the following day. He had no family or
personal history of nontuberculous or pulmonary disease.
Chest computed tomography (CT) showed an irregularly
shaped solitary nodule in the periphery of the left lower
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lobe with microcalcifications and pleural indentation. On
CT at a follow-up appointment 2 weeks after the initial
consultation, the nodule was enlarged (Fig. 1a, b). To diag-
nose the subacutely progressive pulmonary nodule, a CT-
guided lung biopsy was performed in the private hospital.
The histological examination of the biopsy specimens re-
vealed granulomatous inflammation with atypical cells of
various sizes. One week later, the patient was referred to
our hospital. Although we intended to clarify the origin of
the atypical cells and rule out malignancy, the specimen
volume was insufficient for further investigation.
He reported no history of smoking, foreign travel, eating
crab or boar or deer meat, or contact with patients with
active pulmonary tuberculosis. The results of his physical
examinations, including vital signs and consciousness,
were normal. The laboratory data, including lymphocyte
count, C-reactive protein, procalcitonin, gamma globulin,
tumor markers, antineutrophil cytoplasmic antibodies,
anti-HIV antibody, β-D-glucan, aspergillus antigen,
cryptococcus antigen, Interferon-Gamma Release Assay
(T-SPOT.TB®), and antibody to Paragonimus westermani
or P. miyazaki, were unremarkable. Two weeks after the
referral, positron emission tomography (PET)-CT showed
intense FDG uptake in the nodules, with a maximum
standard uptake value (SUV) of 13.94 (Fig. 2).
Owing to his continuous chest pain and subacutely pro-
gressive nodules, which could not be diagnosed using CT-
guided lung biopsy, wedge resection via video-assisted
thoracoscopic surgery was performed in the left lower
lobe. The histological examination revealed an epithelioid
granuloma, with caseating necrosis and calcification, and
pleurisy over the visceral pleurae (Fig. 3a–d). Although a
smear test of the resected lung tissue was negative, the pa-
tient was initially diagnosed with tuberculosis based on
the results of the histological examination. Antitubercu-
lous therapy was initiated with isoniazid, rifampicin, eth-
ambutol, and pyrazinamide. Because the patient presented
with severe skin eruptions and high fever 2 weeks after
initiation of the antituberculous therapy, we paused the
treatment. One week later, the lung tissue culture was
positive for mycobacteria identified as Mycobacterium
avium via DNA-DNA hybridization. His chest pain disap-
peared almost simultaneously. Anti-interferon-γ autoanti-
bodies were negative. We plan to initiate anti-MAC
chemotherapy (rifampicin, ethambutol, and clarithromy-
cin) once these adverse effects have abated, for which the
patient is being closely monitored.
Discussion
To our knowledge, this is the first report regarding
MAC-SPN presenting with persistent chest pain and in-
duced by histologically confirmed pleurisy. Since Gribetz
et al. reported the first case series in 1981 [1], 45
cases of MAC-SPN have been reported: 33 from East
Fig. 1 Computed tomography scan of the chest. a Chest computed
tomography showed an irregularly shaped solitary nodule in the
periphery of the left lower lobe, with microcalcifications (arrow) and
pleural indentation. b After 2 weeks, the nodules became enlarged,
around which ground glass opacity appeared
Fig. 2 Positron emission tomography-computed tomography scan of
the chest. A positron emission tomography-computed tomography
scan showed intense 18F-fluorodeoxyglucose uptake in the nodular
shadow with a maximum standard uptake value of 13.9
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Asia [2–10] and 12 from the USA [1]. MAC-SPN
generally affects middle-aged to elderly (median = 63
years; range: 37–81 years) men and women equally.
The majority of the cases were diagnosed via chest
imaging, and the patients were usually asymptomatic;
however, respiratory symptoms, such as cough, spu-
tum, and hemoptysis, were reported occasionally. In
contrast, our patient was younger and had no respira-
tory symptoms aside from persistent chest pain,
which was induced by histologically confirmed pleur-
isy without pleural effusion (so-called “dry pleurisy”)
caused by M. avium. A report of MAC (not MAC-SPN)
pleurisy in 16 cases with pleural effusion included a pa-
tient who was younger than the patient in the present case
[11]. The factors for the onset of MAC-SPN are unknown.
In the literature, only 7 cases were associated with under-
lying pulmonary disease (4 with old tuberculosis, 2 with
lung cancer, and 1 with emphysema), and none of the pa-
tients were immunocompromised or had a family history
of MAC lung disease. However, given that recent studies
have suggested the importance of genetic or familial sus-
ceptibility to MAC lung disease [12, 13], further studies
are warranted to assess MAC-SPN host factors.
In the present case, lung cancer and tuberculoma were
included in the differential diagnosis of SPN prior to the
definitive diagnosis of MAC-SPN. Distinguishing MAC
from tuberculoma in cases involving an SPN is very
difficult. In a report of 26 patients with tuberculoma and
15 patients with MAC-SPN [8], 10 of the patients with
MAC-SPN were initially diagnosed with tuberculoma
and administered antituberculous medications. The pa-
tients with MAC-SPN were older and had higher max-
imum SUV in PET than the patients with tuberculoma.
In 9 cases of nontuberculous mycobacterium (NTM)
presenting as an SPN [7–9], the mean maximum SUV
on FDG-PET was 8.6 (range: 4.4–13.2). Therefore, the
maximum SUV in the present case (13.9) was higher
than that observed in previous reports. Ruling out lung
cancer should be undertaken with great care, as the co-
existence of lung cancer and MAC pulmonary disease
has been reported [2, 14]. FDG-PET is reportedly useful
for evaluating disease activity and monitoring the thera-
peutic response in patients with NTM lung disease [15],
indicating that high activity of MAC-SPN could cause
pleurisy, as observed in the present case.
In the present case, surgical resection of MAC-SPN
was performed, and we plan to initiate anti-MAC
chemotherapy once the adverse effects have abated,
although the significance of chemotherapy for MAC-
SPN following surgical resection remains controversial.
In the literature, of 45 patients with MAC lung disease
presenting as an SPN, surgical resection was performed
in 16 patients. Of the 14 patients who were administered
anti-MAC chemotherapy after the surgical resection,
Fig. 3 Photograph and photomicrographs of the lung. a Photograph of a cross-sectional specimen in the resected lung showing a granuloma
with caseating necrosis (arrow) and pleurisy (arrowhead). b Photomicrograph showing pleurisy over the visceral pleurae (circle; bar 500 μm),
which revealed granulomatous infiltration. c-d Photomicrograph showing an epithelioid granuloma with necrosis and calcification (arrows)
(C; bar 250 μm, D; bar 25 μm)
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none experienced recurrence; however, this was also true
for the remaining 2 patients who were not administered
anti-MAC chemotherapy [1–5, 7]. Chemotherapy for
MAC-SPN without surgical resection has also been re-
ported as effective, with the size of the SPN decreasing
in 9 of 10 patients undergoing anti-MAC chemotherapy
[10]. In 15 patients with MAC-SPN, 5 did not undergo
any treatment, and the size of the SPN decreased spon-
taneously in 3 patients, was unchanged in 1 patient, and
increased in 1 patient. Anti-MAC chemotherapy was
eventually initiated in 2 of these 5 patients [8]. There-
fore, anti-MAC chemotherapy can be withheld until the
size of an SPN increases, even without surgical therapy.
Conclusion
We report a case with MAC-SPN with high-intensity
FDG uptake and histologically confirmed pleurisy. MAC
should be considered in the differential diagnosis of an
SPN, even for patients who experience persistent chest
pain. Surgical resection with video-assisted thoraco-
scopic surgery is a reasonable approach to the diagnosis
and treatment of MAC-SPN with possible malignancy,
as MAC can be diagnosed using resected lung tissue
culture with histological confirmation.
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